Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05512208
Title A Phase 2 Study of VS-6766 Plus Defactinib
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of Oklahoma
Indications

female reproductive organ cancer

Therapies

Defactinib + RO5126766

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST